Clinical Trial Update: An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)

View source ↗

Summary

An observational prescription-event monitoring study of asenapine (Sycrest) for bipolar I disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Sycrest (asenapine maleate)

Snippet

Sponsor: Professor Saad Shakir | Conditions: Bipolar I Disorder | Status: COMPLETED